Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction

Drugs and Aging

Volumn 23, Issue 8, 2006, Pages 673-680

  Koutouzis, Michael ^a   Nikolidakis, Savvas ^a   Grigoriadis, Anestis ^a   Koutsogeorgis, Dimitrios ^a   Kyriakides, Zenon S ^a  

^a RED CROSS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ESMOLOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BRADYCARDIA; CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; INFUSION; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ATRIAL FUNCTION, RIGHT; BLOOD PRESSURE; FEMALE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPANOLAMINES; PULMONARY WEDGE PRESSURE; STROKE VOLUME; VASCULAR RESISTANCE;

EID: 33748681486     PISSN: 1170229X     EISSN: 1170229X     Source Type: Journal    
DOI: 10.2165/00002512-200623080-00004     Document Type: Article

References (28)

1. Braunwald E, Antman EM, Beasley JW, et al. American College of Cardiology/American Heart Association Committee on the Management of Patients with Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-elevation myocardial infarction. Summary article: a report of the ACC/AHA task force on practice guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2002 Oct 2; 40: 1366-74
2. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-71
3. Herlitz J, Elmfeldt D, Hjalmarson A, et al. Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. Am J Cardiol 1983; 51: 1282-8
4. Nieminen MS, Bohm M, Cowie MR, et al. ESC Committee for Practice Guideline. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416
5. Kyriakides ZS, Papaioannou G, Paraskevaidis IA, et al. Systolic functional response of normal older and younger adult left ventricles to β-blockade during exercise. Cardiovasc Drugs Ther 1995 Apr; 9 (2): 289-94
6. Yin FC, Raizes GS, Guarnieri T, et al. Age-associated decrease in ventricular response to haemodynamic stress during beta-adrenergic blockade. Br Heart J 1978; 40: 1349-55
7. Ahmed A. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure. Eur J Heart Fail 2003; 5 (6): 709-15
8. White M, Leenen FH. Effects of age on cardiovascular responses to adrenaline in man. Br J Clin Pharmacol 1997; 43 (4): 407-14
9. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994; 90 (3): 1225-38
10. Feldman RD. Physiological and molecular correlates of age-related changes in the human beta-adrenergic receptor system. Fed Proc 1986; 45 (1): 48-50
11. Lehmann M, Schmid P, Keul J. Age- and exercise-related sympathetic activity in untrained volunteers, trained athletes and patients with impaired left-ventricular contractility. Eur Heart J 1984; 5 Suppl. E: 1-7
12. GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction: Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto miocardico. Lancet 1994; 343: 1115-22
13. Barbier GH, Shettigar UR, Appunn DO. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. Int J Clin Pharmacol Ther 1995; 33: 212-8
14. Grossman W. Blood flow measurement: the cardiac output. In: Grossman W, Baim DS, editors. Cardiac catheterization, angiography and intervention. 4th ed. Philadelphia (PA): Lea & Febiger, 1991: 105-22
15. Kyriakides ZS, Kremastinos D, Karavolias G, et al. Intravenous atenolol in elderly patients in the early phase of acute myocardial infarction. Cardiovasc Drugs Ther 1992; 6: 475-9
16. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986; 2 (8498): 57-66
17. Metoprolol in acute myocardial infarction: patient population. The MIAMI Trial Research Group. Am J Cardiol 1985; 56 (14): 10G-14G
18. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2001; 104: 2996-3007
19. Gheorghiade M, Colucci WS, Swedberg K. β-blockers in chronic heart failure. Circulation 2003; 107: 1570-5
20. Olivetti G, Melissari Capasso JM, Anversa P. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560-8
21. White M, Leenen FHJ. Aging and cardiovascular responsiveness to β-agonist in humans: role of changes in β-receptor responses versus baroreflex activity. Clin Pharmacol Ther 1994; 56 (5): 543-53
22. Xiao RP, Lakatta EG. Deterioration of β-adrenergic modulation of cardiovascular function with aging. Ann N Y Acad Sci 1992; 673: 293-310
23. Dillon N, Chung S, Kelly J, et al. Age and beta adrenoreceptor mediated function. Clin Pharmacol Ther 1980; 27: 769-72
24. Kyriakides ZS, Kelesides K, Melanidis J, et al. Systolic functional response of normal older and younger adult left ventricles to dobutamine. Am J Cardiol 1986; 58: 816-9
25. Rich MW, Imburgia M. Inotropic response to dobutamine in elderly patients with decompensated congestive heart failure. Am J Cardiol 1990; 65: 519-21
26. Podrazik PM, Schwartz JB. Cardiovascular pharmacology of aging. Cardiol Clin 1999; 17 (1): 17-34
27. Proper R. Left ventricular stroke volume measurements not affected by chronologic aging. Am Heart J 1972; 83: 843-5
28. COMMIT Collaborative Group. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 2005; 366: 1622-32